Surgery Doctors in Newark, NY Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Brian Patrick Watkins, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Driving Park Ave Ste 2, Newark, NY 14513 Phone: 315-359-2670    Fax: 315-359-2675

Abdullah Al-mahayri, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Driving Park Ave, 2nd Floor, Newark, NY 14513 Phone: 315-359-2670

Dr. Allan R Walker, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 120 Linden Ave, Newark, NY 14513 Phone: 315-331-9537

Dr. Kenneth Vincent Toner, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1200 Driving Park Ave, Newark, NY 14513 Phone: 315-359-2670    Fax: 315-359-2675

News Archive

Solvanix set up to commercialise novel antibody-stabilisation technology

The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies.

Vitamin and mineral supplements can enhance mental energy and well-being

Vitamin and mineral supplements can enhance mental energy and well-being not only for healthy adults but for those prone to anxiety and depression, according to a July 15 panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- held at McCormick Place.

Nightingale Health adds urine, CSF and cord blood analysis to its blood biomarker services

Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker testing technology, today announced further steps towards widespread expansion and development of its services.

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

New screening test detects 20 types of cancer

Researchers from the Dana-Farber Cancer Institute have developed a new blood test that would accurately determine the presence of several types of cancers. The results of their multi-centre clinical trial to prove the effectiveness of their test was presented by the researchers at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, on the 28th of September 2019.

Read more Medical News

› Verified 8 days ago